Merz, going for a strong customer focus, recently did something many of its pharma peers have done over the last few years: split into distinct operating businesses. The aesthetics unit, now called Merz Aesthetics, is the largest of the three, beating…
J&J now has to fight thousands more Risperdal claims, thanks to Pennsylvania’s high court
Johnson & Johnson has been battling legal issues on several fronts—ranging from opioids to talc to medical devices—and Wednesday, its fight got a little tougher. Pennsylvania’s Supreme Court ruled that lower courts had erred in dismissing two lawsuits from Risperdal patients…
AHA: Janssen drops clinical sites for smartphones, wearables in 100% virtual Invokana study
Johnson & Johnson’s pharmaceutical arm Janssen is launching its first completely virtual clinical trial, using personal smartphones and wearable devices to track participants with no in-person site visits required. The decentralized study, dubbed CHIEF-HF, aims to gather real-world evidence…
AbbVie signs potential $2.4bn cancer immunotherapy deal with Harpoon
AbbVie has signed a deal worth up to $2.4 billion with the US biotech Harpoon Therapeutics, expanding a research and licensing collaboration involving technology that trains T-cells to target BCMA, a biomarker associated with multiple myeloma. The deal gives AbbVie…
Merit Medical stent graft system gains breakthrough status
Dive Brief: Merit Medical Systems has received FDA breakthrough designation for its endovascular stent graft system, the company said Thursday. The device, which Merit describes as a “flexible, self-expanding endoprosthesis” is designed to treat the narrowing of blood vessels of…
UPS plans to improve healthcare traceability with IoT-enabled logistics
Dive Brief: UPS is planning to launch a new offering for tracking healthcare-related shipments in the first quarter of next year called UPS Premier that will use Internet of Things (IoT) sensors to track packages, according to a press release…
AstraZeneca’s Calquence Wins FDA Approval for Chronic Lymphocytic Leukemia
Two months after snagging Breakthrough Therapy Designation, AstraZeneca’s Calquence wins approval from the U.S. Food and Drug Administration (FDA) for the treatment of adult patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL). The latest approval for Calquence…
Mayo’s Startup Acceleration Project Cuts Timelines Dramatically
Mayo Clinic has cut its study start up times by two-thirds, thanks to administrative restructuring, staff education and new technology. Through its Transforming the Activation of Clinical Trials (TACT) project, the clinic was able to bring study startup times down…
India closer to world’s first male contraceptive injection
The contraceptive is effective for 13 years, after which it loses its potency. It is designed as a replacement for surgical vasectomy, which is the only male sterilisation method available in the world. The Indian Council of Medical Research (ICMR)…
Coming soon: More than 750 inspectors & technicians to regulate medical devices in India
Health Minister Harsh Vardhan says Department of Expenditure has approved the creation of posts to inspect, audit and test the efficacy of medical devices. New Delhi: The Narendra Modi government is set to hire more than 700 inspectors and technicians…